GE HealthCare Technologies Inc. (BMV:GEHC)
Mexico · Delayed Price · Currency is MXN | Market Cap | 568.38B -28.2% |
| Revenue (ttm) | 371.32B +4.8% |
| Net Income | 37.52B +4.6% |
| EPS | 81.91 +4.8% |
| Shares Out | n/a |
| PE Ratio | 15.15 |
| Forward PE | 13.71 |
| Dividend | 2.61 (0.21%) |
| Ex-Dividend Date | Jan 9, 2026 |
| Volume | 156 |
| Average Volume | 3,949 |
| Open | 1,268.00 |
| Previous Close | 1,350.00 |
| Day's Range | 1,268.00 - 1,268.00 |
| 52-Week Range | 1,197.94 - 1,541.00 |
| Beta | n/a |
| RSI | 39.23 |
| Earnings Date | Apr 28, 2026 |
About BMV:GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, an... [Read more]
Financial Performance
In 2025, BMV:GEHC's revenue was $20.63 billion, an increase of 4.84% compared to the previous year's $19.67 billion. Earnings were $2.08 billion, an increase of 4.57%.
Financial numbers in USD Financial StatementsNews
GE HealthCare completes Intelerad acquisition – accelerating shift to cloud-first enterprise solutions to deliver precision care
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced that it has completed the acquisition of Intelerad, a leading medical imaging software provider for the healthcare industry, for a base purchase...
GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE: SYK), to its Board of Directors...
GE HealthCare Technologies Inc. (GEHC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
GE HealthCare Technologies Inc. (GEHC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
GE HealthCare announces U.S. FDA 510(k) clearance for View, a next‑generation diagnostic viewer enabling anywhere‑access to radiologists
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced that View, the powerful viewer within the Genesis™ Radiology Workspace, has received 510(k) clearance from the U.S. Food and Drug Administration...
These stocks in the S&P 500 have dropped the most since the U.S. and Israel attacked Iran
A disappointing Friday employment report helped send stocks down further, with cruise operators hammered
GE HealthCare to showcase AI and digital leadership at HIMSS 2026
LAS VEGAS--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will showcase innovations moving healthcare forward at the Health Information and Management Systems Society (HIMSS) Global Health Conference &...
GE HealthCare Technologies Inc. (GEHC) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
GE HealthCare Technologies Inc. (GEHC) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
What's Going On With GE HealthCare Technologies Stock?
The FDA has recently approved GE HealthCare's next-generation SIGNA MRI technology, which is designed to enhance precision imaging and clinical efficiency. This milestone is significant as it includes...
GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with the U.S. Food and Drug Administration (FDA): SIGNA™ Sprint...
GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance artificial intelligence-powered ultrasound for trauma care and emergency preparedness
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a new approximately $35 million expansion to a previous contract with the Biomedical Advanced Research and Development Authority ...
GE HealthCare announces cash dividend for first quarter of 2026
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 paya...
GE HealthCare management to present at upcoming investor conferences
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. Citi's 2026 Unplugged MedTech and ...
GE HealthCare launches ReadyFix fleet management solution to help enhance operational efficiency and reliable patient care
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the United States launch of ReadyFix™, a remote fleet management solution designed to help healthcare systems support device upti...
GE HealthCare Technologies Pops, And The Upside Isn't Over Yet
GE HealthCare Technologies delivered strong Q4 2025 results, with revenue and adjusted EPS exceeding analyst expectations and robust segmental growth. GEHC remains a 'buy' as shares are attractively v...
GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript
GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript
GE HealthCare Beats Earnings But Margin Pressure, Tariff Costs Could Weigh On Profitability
GE HealthCare (NASDAQ: GEHC) on Wednesday reported adjusted earnings of $1.44 per share, beating the consensus of $1.40.
GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices
GE HealthCare on Wednesday forecast annual profit above Wall Street estimates, betting on robust demand for its diagnostic and imaging devices.
GE HealthCare Stock Rises. Why Earnings Were a Relief.
Wednesday, GE HealthCare reported fourth-quarter earnings per share of $1.44 from sales of $5.7 billion. Wall Street was looking for earnings per share of $1.40 from sales of $5.6 billion.
GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue
GE HealthCare Technologies said profit fell in the fourth quarter, despite higher revenue, as the company continues to operate in what Chief Executive Peter Arduini called a dynamic macroeconomic envi...
GE HealthCare reports fourth quarter and full year 2025 financial results
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2025. GE HealthCare President and CEO Peter Arduini said...
GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced that Allia™ Moveo has received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Marking, bringing next-level mobil...
3 S&P 500 Stocks to Sell in 2026
The S&P 500 is chugging along at a solid rate, as it's up 17% over the past year and up 2.5% over the past month. Market mavens should like what they see as the index crests the 6,950 mark, with 7,300...
Pharma sector doubles down on AI amid hopes of slashing costs, timelines
Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools and automated labs to unlock efficiency gains across their pipeline.
Sell GE HealthCare Stock, UBS Says. The Risks Aren't Known.
Investors aren't concerned enough about China competition or a generic rival, UBS says.
GE HealthCare Technologies Inc. (GEHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
GE HealthCare Technologies Inc. (GEHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript